CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Globus Medical, Inc. - GMED CFD

84.95
1.96%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.26
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024346 %
Charges from full value of position ($-4.63)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002124 %
Charges from full value of position ($0.40)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002124%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 83.32
Open 83.7
1-Year Change 69.3%
Day's Range 83.7 - 85.09
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 17, 2024 83.32 2.96 3.68% 80.36 84.00 80.36
Dec 16, 2024 81.30 -0.60 -0.73% 81.90 82.74 81.30
Dec 13, 2024 82.05 -0.45 -0.55% 82.50 82.50 81.50
Dec 12, 2024 82.63 -0.07 -0.08% 82.70 84.06 82.47
Dec 11, 2024 82.83 0.38 0.46% 82.45 83.59 82.42
Dec 10, 2024 82.82 0.76 0.93% 82.06 83.75 82.06
Dec 9, 2024 82.79 -0.04 -0.05% 82.83 83.43 82.50
Dec 6, 2024 82.95 0.00 0.00% 82.95 83.51 82.50
Dec 5, 2024 82.76 -0.76 -0.91% 83.52 83.90 82.76
Dec 4, 2024 84.04 0.06 0.07% 83.98 85.50 83.78
Dec 3, 2024 84.76 1.76 2.12% 83.00 85.20 81.66
Dec 2, 2024 83.75 -2.90 -3.35% 86.65 86.68 83.47
Nov 29, 2024 85.50 0.26 0.31% 85.24 85.89 84.57
Nov 27, 2024 85.22 1.10 1.31% 84.12 85.66 83.87
Nov 26, 2024 84.17 -0.22 -0.26% 84.39 84.62 83.46
Nov 25, 2024 84.15 0.00 0.00% 84.15 85.01 83.73
Nov 22, 2024 84.54 2.19 2.66% 82.35 85.11 82.35
Nov 21, 2024 84.66 1.71 2.06% 82.95 84.93 82.03
Nov 20, 2024 83.31 0.67 0.81% 82.64 83.83 82.35
Nov 19, 2024 83.25 2.49 3.08% 80.76 83.30 80.03

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Globus Medical, Inc. Company profile

About Globus Medical Inc

Globus Medical, Inc. is a medical device company. The Company is primarily focused on implants that promote healing in patients with musculoskeletal disorders. The Company group its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery, which are computer-assisted intelligent systems designed to improve a surgeon’s capabilities, and ultimately improve patient care and reduce radiation exposure for all involved. Its INR solutions include the ExcelsiusGPS platform, which is a robotic guidance and navigation system that supports minimally invasive and open procedures with screw and interbody spacer placement applications.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Globus Medical Inc revenues increased 21% to $958.1M. Net income increased 46% to $149.2M. Revenues reflect Musculoskeletal Solutions products segment increase of 17% to $876.8M, Enabling Technologies products segment increase of 100% to $81.3M, United States segment increase of 23% to $819.6M, International segment increase of 11% to $138.5M.

Equity composition

Cls A Common stock $.001 Par 8/12, 500M auth., 62,503,441 issd., Insiders own approx. 86.70%. Cls B Common Stock 275M auth., 27,885,000 issd.

Industry: Medical Equipment, Supplies & Distribution (NEC)

2560 General Armistead Ave
AUDUBON
PENNSYLVANIA 19403
US

People also watch

US100

22,000.70 Price
+0.160% 1D Chg, %
Long position overnight fee -0.0243%
Short position overnight fee 0.0021%
Overnight fee time 22:00 (UTC)
Spread 1.8

BTC/USD

104,103.90 Price
-1.970% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

XRP/USD

2.48 Price
-5.310% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01235

ETH/USD

3,860.12 Price
-1.840% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading